E-mail a Wiley Online Library Link

Massimo Cristofanilli Novel targeted therapies in inflammatory breast cancer Cancer 116

Article first published online: 19 MAY 2010 | DOI: 10.1002/cncr.25172

Inflammatory breast cancer is an aggressive form of locally advanced breast cancer characterized by rapid disease onset. Targeting key molecular markers, such as HER2, with novel therapeutic agents (trastuzumab and lapatinib) may improve prognosis.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field